Bessemer Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-561
Closed -$9K 2547
2025
Q4
$9K Sell
561
-67
-11% -$738 ﹤0.01% 2124
2025
Q3
$6K Buy
628
+104
+20% +$1.08K ﹤0.01% 2083
2025
Q2
$5K Sell
524
-856
-62% -$9.02K ﹤0.01% 2015
2025
Q1
$18K Buy
1,380
+794
+135% +$10.5K ﹤0.01% 1576
2024
Q4
$8K Buy
586
+50
+9% +$605 ﹤0.01% 1848
2024
Q3
$6K Buy
536
+189
+54% +$2.08K ﹤0.01% 1843
2024
Q2
$4K Sell
347
-107
-24% -$1.25K ﹤0.01% 1746
2024
Q1
$5K Buy
454
+347
+324% +$4.53K ﹤0.01% 1701
2023
Q4
$2K Hold
107
﹤0.01% 2021
2023
Q3
$2K Hold
107
﹤0.01% 1967
2023
Q2
$1K Buy
+107
New +$1.22K ﹤0.01% 2141
2016
Q1
Sell
-423
Closed -$10K 1522
2015
Q4
$10K Buy
+423
New +$10.6K ﹤0.01% 1220

Other funds holding DVAX

Bessemer Group's DVAX Position: Q1 2026 in Review

Bessemer Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 561 shares — an estimated $9K sold.

Bessemer Group first reported a position in DVAX in Q4 2015 and held it in 12 quarters. The position peaked at $18K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Bessemer Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Bessemer Group sold 561 Dynavax Technologies shares in Q1 2026, an estimated $9K.
  • Bessemer Group first reported a position in Dynavax Technologies in Q4 2015 and held it in 12 quarters.
  • Bessemer Group's Dynavax Technologies position peaked at $18K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.